Opinion: Remembering David Swensen, a giant in the investment world
By David Kreinces In early May, David Swensen, Yale’s legendary endowment chief, died of cancer at age 67. Swensen was famous on Wall Street for successfully diversifying Yale’s portfolio in a wide range of alternative investments, and he was also loved for his 2005 book on exchange-traded funds (ETFs). The book, “Unconventional Success,” showed Swensen’s Read More →
Amgen gets FDA approval for potential billion-dollar drug
Thousand Oaks-based Amgen won approval from the U.S. Food and Drug Administration on May 28 for its latest oral drug treatment, Lumakras, potentially adding another huge market for one of the largest biotech firms in the world. According to the Wall Street Journal, Amgen will charge $17,900 a month for the drug and analyst think Read More →
QAD stock rises after earnings beat
QAD, a Santa Barbara-based cloud software company for the manufacturing industry, beat analysts’ expectations with its earning for the first quarter of its 2021-22 fiscal year on May 26. QAD’s net income for the quarter was $1.8 million, or 7 cents per share, compared to a loss of $410,000 in the same quarter a year Read More →
Deckers shares rise on news of record sales and earnings
Shares of Deckers Brands, the Goleta-based parent company of Ugg and other footwear brands, jumped 7% on May 20 following the announcement of its fourth quarter and full-year 2020 financial results, which included big jumps in both revenue and net income. Net sales increased 19.4% from 2019 to 2020, to $2.5 billion, the most in Read More →
Procore goes public, stock jumps 34%
Editor’s note: This article was updated after the market closed at 1 p.m. to reflect Procore’s closing price. Carpinteria-based Procore Technologies began trading on the New York Stock Exchange on May 20 and saw its share price shoot up 33.7% on its first day, to close at $89.59. Procore priced shares of its initial public Read More →
Cure reports net loss, rising revenue in Q1
Oxnard-based Cure Pharmaceutical saw another spike in revenue in the first quarter of 2021, but net losses also continued to grow. Cure had $1.5 million in revenue in the quarter ended March 31, up 400% from the first quarter of 2020, according to the company’s earnings report, released May 17. The bulk of that growth Read More →
Procore awaits IPO
Editor’s note: This article was updated May 19 to reflect the fact that Procore did not begin trading that day. The Carpinteria-based software company Procore Technologies expects to raise around $615 million in an IPO scheduled for no later than May 21. The Procore IPO is on the New York Stock Exchange’s calendar for the Read More →
